GlobalData, Sep 2011, Pages: 78
Endometriosis Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Summary
GlobalData, the industry analysis specialist, has released its new report, “Endometriosis Therapeutics
GlobalData, Dec 2010, Pages: 39
“Endometriosis - Pipeline Assessment and Market Forecasts to 2017” report is an essential source of information and analysis on the global endometriosis market. The report identifies the key trends
Datamonitor, Dec 2009, Pages: 147
trial size
Placebo versus active control
Trial endpoints in endometriosis
Pain
Quality of Life
Disease regression and Infertility
4. Pipeline Analysis & Forecasts
Key findings
Overview
Pipeline
GBI Research, Jan 2012, Pages: 114
2002 to 2010, forecast to 2017.
- Analysis of the leading therapeutic segments, including endometriosis, postmenopausal osteoporosis, menopause and urinary incontinence
- Analysis of the women’s health
Frost & Sullivan, July 2007, Pages: 78
--- Profiles of Key Industry Participants
--- Competitive Landscape
--- Pipeline Analysis
- Total Forecasts for the European Endometriosis Therapeutics Market
-- Market Revenue Forecasts
--- Total
GBI Research, Aug 2010, Pages: 132
Disorder Therapeutics Market: Pipeline Analysis 92
6.1 Introduction 92
6.1.1 Research and Development Pipeline - Menopause 94
6.1.2 Research and Development Pipeline - Endometriosis 96
6
Datamonitor, Oct 2009
and generic drugs to 2018 in the US, Japan, France, Germany, Italy, Spain, and the UK.
- Evaluate the sales forecasts of key pipeline drugs to 2018 in the US, Japan, France, Germany, Italy, Spain, and the UK
Spectra Intelligence, Sep 2007, Pages: 350
.
The pipeline however is vast with over 75 hormonal products in clinical development that will offer purer analogues, low-dose formulations, new delivery modes and formats, novel mechanisms of action, and which
GlobalData, June 2010, Pages: 187
market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report
Global Markets Direct, Dec 2009, Pages: 164
, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Asia Pacific
Scope
Fuji-Keizai USA, Inc., Feb 2005, Pages: 151
by Indication
2.9.4 Urologic & Kidney Drug R&D Pipeline & Commercial Implication Indication
2.9.5 Important Finding (Special Note)
3. Women's Health Rx Drug Market Size Forecast by Disease
3.1 Total
Datamonitor, Dec 2008, Pages: 189
.
Reasons to Purchase
- Target physicians more effectively through an understanding of prescribing behavior and its influences.
- Validate new product forecasting based on diagnosis and treatment rates
